| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W J Weiner, P M Carvey, P A Nausieda, H L Klawan. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior. Neurology. vol 29. issue 12. 1980-01-28. PMID:41197. |
the dopamine antagonist haloperidol potentiated jumping behavior. |
1980-01-28 |
2023-08-11 |
human |
| C A Greer, H P Alper. Maturational changes related to dopamine in the effects of d-amphetamine, cocaine, nicotine, and strychnine on seizure susceptibility. Psychopharmacology. vol 64. issue 3. 1980-01-28. PMID:116267. |
these effects were not attenuated by haloperidol, indicating mediation by systems other than dopamine. |
1980-01-28 |
2023-08-11 |
mouse |
| G Stüttgen, R Dreese. Dopamine effects on the microcirculation and veins of the skin after local application and their changes by antagonistic drugs. Archives of dermatological research. vol 266. issue 1. 1980-01-28. PMID:507930. |
oral haloperidol has no influence on the dopamine skin reaction, but increases the blanching in areas of antihistamine treatment. |
1980-01-28 |
2023-08-11 |
Not clear |
| R Jork, B Lössner, H Matthie. Dopamine and macromolecule synthesis in rat hippocampus. Pharmacology, biochemistry, and behavior. vol 11. issue 2. 1980-01-24. PMID:504305. |
noradrenaline did not alter the incorporation of both precursors, whereas haloperidol partially reduced the dopamine induced increase in incorporation of fucose. |
1980-01-24 |
2023-08-11 |
rat |
| J M Mont. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat. British journal of pharmacology. vol 67. issue 1. 1980-01-19. PMID:40644. |
2 haloperidol (0.6 mg/kg), which blocks central dopamine and noradrenaline (na) receptors, reversed the eeg desynchronizing actions of l-dopa and (+)-amphetamine. |
1980-01-19 |
2023-08-11 |
rat |
| B H Westerink, A S Hor. Do neuroleptics prevent the penetration of dopamine agonists into the brain? European journal of pharmacology. vol 58. issue 1. 1980-01-19. PMID:40803. |
suppression of the accumulation of the dopamine agonist 6,7-adtn (administered as the prodrug dibenzoyl-6,7-adtn) was seen after combined treatment with haloperidol or reserpine, whereas cis- and trans-flupenthixol were without effect. |
1980-01-19 |
2023-08-11 |
Not clear |
| G B Stefano, I Vadasz, L Hirip. Naloxone selectively blocks dopamine response of Br-type neuron in Helix pomatia L. Experientia. vol 35. issue 10. 1980-01-19. PMID:499413. |
the dopamine inhibitory affect can also be blocked by haloperidol, a established dopamine receptor blocker. |
1980-01-19 |
2023-08-11 |
Not clear |
| P Hirszel, M Lasrich, J F Mahe. Augmentation of peritoneal mass transport by dopamine: comparison with norepinephrine and evaluation of pharmacologic mechanisms. The Journal of laboratory and clinical medicine. vol 94. issue 5. 1980-01-19. PMID:501201. |
the augmentation of solute transport by dopamine was unaffected by simultaneous administration of propranalol, was decreased by phentolamine, and was abolished by haloperidol. |
1980-01-19 |
2023-08-11 |
Not clear |
| T Quesada, L Garcia-Torres, F Alba, C Garcia del Ri. The effects of dopamine on renin release in the isolated perfused rat kidney. Experientia. vol 35. issue 9. 1979-12-29. PMID:488280. |
in the isolated and perfused kidney of the rat, the stimulant effect of dopamine on renin release is blocked by propranolol and not by haloperidol. |
1979-12-29 |
2023-08-11 |
rat |
| L Kh Allikmets, A M Zharkovskiĭ, M Ia Otter, T Kh Khinriku. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. vol 29. issue 5. 1979-12-29. PMID:573939. |
in experiments on male albino rats single administration of haloperidol produced catalepsy, increase in dopamine turnover, enhancement of main dopamine metabolite homovanilinic acid in the forebrain. |
1979-12-29 |
2023-08-11 |
rat |
| L Kh Allikmets, A M Zharkovskiĭ, M Ia Otter, T Kh Khinriku. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. vol 29. issue 5. 1979-12-29. PMID:573939. |
thus, it appears that chronic administration of haloperidol reduces the sensitivity of dopamine receptors, and chronic administration of levomepromazine--reduces the sensitivity of dopamine and serotonin receptors in the brain. |
1979-12-29 |
2023-08-11 |
rat |
| M T Lin, Y F Chern, H S Wang, A Chandr. Effects of gamma-hydroxybutyric acid on metabolic, respiratory and vasomotor activities and body temperature in rats. The Journal of pharmacology and experimental therapeutics. vol 211. issue 1. 1979-12-20. PMID:158642. |
furthermore, it was found that the ghba-induced hypothermia was antagonized by haloperidol (a selective blocker of dopamine receptors), but not by p-chlorophenylalanine (an inhibitor of serotonin synthesis). |
1979-12-20 |
2023-08-11 |
rat |
| A G Phillips, H C Fibige. Decreased resistance to extinction after haloperidol: implications for the role of dopamine in reinforcement. Pharmacology, biochemistry, and behavior. vol 10. issue 5. 1979-12-18. PMID:493290. |
decreased resistance to extinction after haloperidol: implications for the role of dopamine in reinforcement. |
1979-12-18 |
2023-08-11 |
Not clear |
| P C Goldsmith, M J Cronin, R I Weine. Dopamine receptor sites in the anterior pituitary. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. vol 27. issue 8. 1979-11-29. PMID:383827. |
dopamine receptors were labeled with the antagonist haloperidol. |
1979-11-29 |
2023-08-11 |
rat |
| L Kokkinidis, H Anisma. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement. Psychopharmacology. vol 64. issue 1. 1979-11-28. PMID:113831. |
similarly, blockade of b-adrenergic receptors by propranolol and dopamine receptors by haloperidol reversed the circling response elicited by amphetamine. |
1979-11-28 |
2023-08-11 |
mouse |
| C Chevillard, M N Mathie. Mechanism of the depressor response to dopamine in the rat treated with phenoxybenzamine. European journal of pharmacology. vol 56. issue 4. 1979-11-28. PMID:477731. |
dopamine produced an enhancement of plasma adrenaline and noradrenaline levels, which was decreased by d,1-propranolol and increased by haloperidol. |
1979-11-28 |
2023-08-11 |
rat |
| M I Fekete, J P Herman, B Kanyicska, M Palkovit. Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline. Journal of neural transmission. vol 45. issue 3. 1979-11-21. PMID:479873. |
dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (dopac) levels of individual brain nuclei, effects of haloperidol and pargyline. |
1979-11-21 |
2023-08-11 |
rat |
| W J Lang, O L Woodma. Cardiovascular responses produced by the injection of dopamine into the cerebral ventricles of the unanaesthetized dog. British journal of pharmacology. vol 66. issue 2. 1979-10-26. PMID:465876. |
3 the dopamine receptor antagonists, haloperidol (500 microgram), chlorpromazine (200 micrograms) and ergometrine (500 micrograms), each given i.c.v., sugsequently abolished the cardiovascular responses to dopamine. |
1979-10-26 |
2023-08-11 |
dog |
| J F Patterso. Treatment of chorea gravidarum with haloperidol. Southern medical journal. vol 72. issue 9. 1979-10-26. PMID:472859. |
a possible neuropharmacologic explanation of the beneficial effects of the neuroleptics, particularly haloperidol, is offered based on the dopamine antagonism of these drugs. |
1979-10-26 |
2023-08-11 |
Not clear |
| S M Wuerthele, N M Friedle, K E Moor. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat. Journal of neural transmission. vol 45. issue 2. 1979-10-24. PMID:469523. |
systemic administration of haloperidol to rats failed to alter the concentration of dopamine but increased the concentration of 3,4-dihydroxy-phenylacetic acid (dopac), the major metabolite of dopamine, in both the striatum and substantia nigra. |
1979-10-24 |
2023-08-11 |
rat |